To our knowledge, our retrospective analysis of colorectal cancer is the first study to measure patient outcome in relation to tumor ascorbate content and to show that this is associated with activation of HIF-1, a known driver of tumor growth and metastasis. The gene discussed is HIF1A; the disease is colorectal cancer.